Clinical Trial Update: Stromal Vascular Fraction (SVF) for Treatment of Enterocutaneous Fistula (HULPUTC) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on Stromal Vascular Fraction (SVF) for enterocutaneous fistula, covering Phase 1 and Phase 2; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterocutaneous Fistula

Drugs mentioned

• Stromal Vascular Fraction (SVF)

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Enterocutaneous Fistula | Phase 1, Phase 2 | Status: UNKNOWN